We are live on ! Find out more
PCVX icon

Vaxcyte
PCVX

223 hedge funds and large institutions have $6.51B invested in Vaxcyte in 2023 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 86 increasing their positions, 69 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

236% more call options, than puts

Call options by funds: $9.9M | Put options by funds: $2.94M

131% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 16

26% more capital invested

Capital invested by funds: $5.17B → $6.51B (+$1.34B)

25% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 69

10% more funds holding

Funds holding: 202 → 223 (+21)

8% more funds holding in top 10

Funds holding in top 10: 13 → 14 (+1)

0.88% more ownership

Funds ownership: 108.03% → 108.91% (+0.88%)

Holders
223
Holders Change
+21
Holders Change %
+10.4%
% of All Funds
3.25%
Holding in Top 10
14
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+7.69%
% of All Funds
0.2%
New
37
Increased
86
Reduced
69
Closed
16
Calls
$9.9M
Puts
$2.94M
Net Calls
+$6.96M
Net Calls Change
+$6.35M

Top Buyers

1
BlackRock
BlackRock
New York
+$60M
2
Morgan Stanley
Morgan Stanley
New York
+$34.5M
3
DGM
Darwin Global Management
Jersey
+$30.1M
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$23.5M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$20M

Top Sellers

1
MVM
Medicxi Ventures Management
Jersey
-$53.5M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$32.3M
3
FAM
Fred Alger Management
New York
-$22M
4
NIP
Nicholas Investment Partners
California
-$18.1M
5
B
Braidwell
Connecticut
-$17.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
MS
226
Maven Securities
Jersey
– -$3.44M -67,500 Closed
RAM
227
Readystate Asset Management
Illinois
– -$2.98M -58,472 Closed
TI
228
Trexquant Investment
Connecticut
– -$2.21M -43,329 Closed
LCG
229
Lisanti Capital Growth
New York
– -$1.78M -34,970 Closed
SG Americas Securities
230
SG Americas Securities
New York
– -$1.43M -27,980 Closed
BFM
231
Boothbay Fund Management
New York
– -$1.42M -27,919 Closed
Citadel Advisors
232
Citadel Advisors
Florida
– -$1.15M -22,106 Closed
EI
233
EAM Investors
California
– -$881K -17,289 Closed
GCM
234
Graham Capital Management
Connecticut
– -$361K -7,082 Closed
XT
235
XTX Topco
Cayman Islands
– -$239K -4,696 Closed
MCM
236
Manchester Capital Management
Vermont
– -$76.5K -1,500 Closed
HNB
237
Huntington National Bank
Ohio
– -$918 -18 Closed
TFGT
238
TS Financial Group (TSFG)
Illinois
– -$1K -7 Closed
MPWT
239
MassMutual Private Wealth & Trust
Connecticut
– -$306 -6 Closed
6 7 8 9
10

PCVX Hedge Fund Activity: Q4 2023 in Review

223 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Vaxcyte (PCVX) for Q4 2023, worth a combined $6.51B — up 26% from $5.17B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new PCVX positions and 16 closed out — a net gain of 21 holders — while 86 added to existing stakes and 69 trimmed.

The largest buyer was BlackRock, adding an estimated $60M. The largest seller was Medicxi Ventures Management, exiting entirely with an estimated $53.5M sold.

  • 223 institutional investors held Vaxcyte (PCVX) as of Q4 2023, up from 202 in Q3 2023.
  • Funds reported $6.51B of Vaxcyte stock for Q4 2023, up 26% quarter-over-quarter.
  • 37 funds opened new Vaxcyte positions in Q4 2023 and 16 closed out, a net change of +21 holders.
  • The largest Vaxcyte buyer in Q4 2023 was BlackRock, an estimated $60M added.
  • The largest Vaxcyte seller in Q4 2023 was Medicxi Ventures Management, an estimated $53.5M sold.

Based on aggregated 13F filings for Q4 2023.